Dr. Gottlieb said transactions like the CVS Health-Aetna or Cigna-Express Scripts deals could make it easier for drugmakers to limit access to cheaper generic drugs that compete with their own brand-name products.
“We don’t have direct purview over it, but we do have something to say about it, and we’re going to be speaking to the PBMs about it,” Dr. Gottlieb said at the conference, according to Reuters.
The FDA head also shared the agency’s plans to create about a dozen policies to encourage more competition between expensive biotech medicines and their biosimilar versions.
More articles on supply chain:
Study: 40% of providers have canceled surgeries over supply shortages
10 immensely overinflated hospital costs
California leads way on drug pricing transparency with other states poised to follow: 6 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
